STOCK TITAN

Cardinal Health (NYSE: CAH) details Q1 results and FY 2026 outlook

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Cardinal Health, Inc. filed a current report to note that it has released financial results for the quarter ended September 30, 2025. The company issued a news release, which is furnished as Exhibit 99.1, summarizing its first-quarter performance.

The report also explains that the Chief Executive Officer and Chief Financial Officer will host a webcast at 8:30 a.m. Eastern time on October 30, 2025 to discuss the quarterly results and the outlook for the fiscal year ending June 30, 2026. A slide presentation and an audio replay of the webcast will be available on the Investors page of Cardinal Health’s website.

Positive

  • None.

Negative

  • None.
0000721371false00007213712025-10-302025-10-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 30, 2025
Cardinal Health, Inc.
(Exact name of registrant as specified in its charter)
Ohio1-1137331-0958666
(State or other
jurisdiction of incorporation)
(Commission
File Number)

(IRS Employer
Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017
(614) 757-5000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares (without par value)CAHNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   p



Item 2.02: Results of Operations and Financial Condition
On October 30, 2025, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended September 30, 2025. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure
During a webcast scheduled to be held at 8:30 a.m. Eastern time on October 30, 2025, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended September 30, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.
Item 9.01: Financial Statements and Exhibits
(d) Exhibits
Exhibit
Number
Exhibit Description
99.1
News release issued by the Company on October 30, 2025 announcing first-quarter results.


2


Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc.
(Registrant)
Date:October 30, 2025By:/s/ AARON E. ALT
Aaron E. Alt
Chief Financial Officer

3

FAQ

What did Cardinal Health (CAH) disclose in this Form 8-K?

Cardinal Health (CAH) disclosed that it issued a news release announcing its financial results for the quarter ended September 30, 2025, which is furnished as Exhibit 99.1.

Which period’s results did Cardinal Health (CAH) report?

The company reported its financial results for the quarter ended September 30, 2025, described in the filing as first-quarter results.

Where can investors find Cardinal Health’s first-quarter 2025 results?

Investors can review the news release containing the first-quarter results in Exhibit 99.1 to the report and access related materials on the Investors page at ir.cardinalhealth.com.

Is Cardinal Health (CAH) holding an earnings webcast for this quarter?

Yes. The Chief Executive Officer and Chief Financial Officer are scheduled to host a webcast at 8:30 a.m. Eastern time on October 30, 2025 to discuss the quarterly results and the outlook for the fiscal year ending June 30, 2026.

Will a replay of Cardinal Health’s earnings webcast be available?

Yes. An audio replay of the webcast will be available on the Investors page at ir.cardinalhealth.com.

What exhibit is attached to this Cardinal Health (CAH) Form 8-K?

The filing includes Exhibit 99.1, which is the news release issued on October 30, 2025 announcing Cardinal Health’s first-quarter results.

Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Latest News

CAH Latest SEC Filings

CAH Stock Data

50.19B
236.94M
0.28%
88.38%
3.01%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN